NoSAS Score: Clinical Guide

Clinical guide to NoSAS Score with method, interpretation, assumptions, limitations, FAQs and references.

Screens adults for risk of clinically significant sleep-disordered breathing using neck circumference, obesity, snoring, age and sex.

Overview

Screens adults for risk of clinically significant sleep-disordered breathing using neck circumference, obesity, snoring, age and sex.

Clinical Significance

A total of 8 or more is conventionally a positive screen for clinically significant sleep-disordered breathing. The score estimates risk and does not establish diagnosis or severity.

When to Use

  • Use when the patient and clinical question match the population and purpose described.
  • Use accurate current inputs and preserve the original score definitions.

How It Is Calculated

  • NoSAS assigns 4 points for neck circumference >40 cm; 3 points for BMI 25 to <30 kg/m² or 5 points for BMI ≥30 kg/m²; 2 points for snoring; 4 points for age >55 years; and 2 points for male sex. Total range 0–17.

Interpretation

  • A total of 8 or more is conventionally a positive screen for clinically significant sleep-disordered breathing. The score estimates risk and does not establish diagnosis or severity.

Worked Example

Enter a complete, clinically consistent set of values. MedicalC then applies the published method: NoSAS assigns 4 points for neck circumference >40 cm; 3 points for BMI 25 to 55 years; and 2 points for male sex. Total range 0–17.

Patient Considerations

  • Derived and validated in adult population cohorts. Performance may differ in pregnancy, children, craniofacial syndromes, neuromuscular disease and highly selected sleep-clinic populations.

Limitations

  • Do not use as a substitute for sleep study assessment. Screening sensitivity and specificity vary with population, sex distribution, ethnicity, referral setting and the apnoea-hypopnoea threshold used.
  • Performance and calibration may differ outside the derivation and validation settings.
  • The result supports but does not replace clinical assessment, investigation or local guidance.

Clinical Pearls

  • NoSAS deliberately uses only five readily available variables, which can improve completion compared with longer questionnaires.
  • Document component values as well as the final result.

Common Mistakes

  • Using an incorrect threshold, unit or category definition.
  • Applying the tool to a population for which it has not been validated.
  • Treating the calculated category as a diagnosis or automatic treatment instruction.

Evidence Base

Marti-Soler H et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med. 2016;4:742–748.

Frequently Asked Questions

What is this tool used for?

Screens adults for risk of clinically significant sleep-disordered breathing using neck circumference, obesity, snoring, age and sex.

Can the result be used on its own?

No. It must be interpreted with the full clinical assessment and appropriate investigations.

What is the main limitation?

Do not use as a substitute for sleep study assessment. Screening sensitivity and specificity vary with population, sex distribution, ethnicity, referral setting and the apnoea-hypopnoea threshold used.

Who was the method designed for?

Derived and validated in adult population cohorts. Performance may differ in pregnancy, children, craniofacial syndromes, neuromuscular disease and highly selected sleep-clinic populations.

What should be reviewed after calculation?

Review symptoms, witnessed apnoeas, daytime impairment, resistant hypertension, atrial fibrillation, occupational driving risk and access to home respiratory polygraphy or polysomnography.

References

  1. Marti-Soler H et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med. 2016;4:742–748. — Primary or authoritative source supporting the implemented method.

Reviewed by: MedicalC Clinical Editorial Team
Last reviewed: July 2026

Return to calculator